Apigenin improves cognitive impairments in the rat model of post-stroke cognitive deficits, through decreased HDAC content, up-regulation H3 and H4 acetylation in the hippocampus and increased the level of BDNF in dose-dependent manner. This evidence concerns the gene BDNF and stroke disorder.